Soberino, Jesús
Racca, Fabricio
Pérez-García, José
García-Fernández, Luis F.
Cortés, Javier
Article History
First Online: 13 November 2019
Compliance with Ethical Standards
:
: Jesús Soberino reports personal fees and other from Roche, personal fees from Eisai, and other from Merck Sharp & Dohme (MSD) outside the submitted work. José Pérez-García reports work with Roche and Lilly outside the submitted work. Javier Cortés reports grants, personal fees, and other from Roche; personal fees and other from Celgene; work with Cellestia; grants and other from AstraZeneca; work with Biothera Pharmaceuticals; work with Merus; work with Seattle Genetics; work with Daiichi Sankyo; work with Erytech; work with Athenex; work with Pholypor; work with Lilly; work with Servier; personal fees from Novartis, grants, and personal fees from Eisai; grants and personal fees from Pfizer; personal fees from Samsung; grants from Ariad Pharmaceuticals; grants from Baxalta GmbH/Servier Affaires; grants from Bayer HealthCare; grants from F. Hoffman-La Roche; grants from Guardant Health; grants from Merck Sharp & Dohme (MSD); grants from PIQUR Therapeutics; grants from Puma Biotechnology; grants from Queen Mary University of London; and work with MedSIR outside the submitted work. Fabricio Racca and Luis F. García-Fernández declare no conflicts of interest relevant to this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.